Jeff Huber - 02 Jan 2026 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Director
Signature
/s/ Bhaskar Anand, as Attorney-in-Fact for Jeff Huber
Issuer symbol
SMMT
Transactions as of
02 Jan 2026
Net transactions value
+$86,593
Form type
4
Filing time
06 Jan 2026, 18:49:36 UTC
Previous filing
25 Nov 2025
Next filing
04 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Huber Jeff Director C/O SUMMIT THERAPEUTICS INC., 601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI /s/ Bhaskar Anand, as Attorney-in-Fact for Jeff Huber 06 Jan 2026 0001463740

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Stock Option (right to buy) Award +35,000 35,000 02 Jan 2026 Common Stock 35,000 $17.52 Direct F1, F2
transaction SMMT Stock Option (right to buy) Award $86,593 +9,885 $8.76 9,885 02 Jan 2026 Common Stock 9,885 $17.52 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the reporting person remaining as a non-salaried director on each such vesting date.
F2 Not applicable.
F3 The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date.
F4 The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $86,600.